Complementarily, pharmacological blockade of AQP4 right after stroke has shown protective effects; treating mice with the AQP4 inhibitor TGN-020 within 1 h of MCAO decreased brain swelling at 24 h and improved long-term functional recovery [19,21]. The gene discussed is AQP4; the disease is Stroke.